EP3613745
Föst form og lyfjaformúleringar af (S)-4-(8-amínó-3-(1-(bút-2-ýnóýl)pyrrólidín-2-ýl)imídasó[1,5-a]pýrasín-1-ýl)-N-(pýridín-2-ýl)bensamíði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.7.2016EP published:
1.9.2021EP application number:
19196939.3
EP translation filed:
19.10.2021Grant published:
15.11.2021EPO information:
European Patent Register
Max expiry date:
30.6.2036Expiry date:
30.6.2026Next due date:
30.7.2026
Title:
SOLID FORMS AND FORMULATIONS OF (S)-4-(8-AMINO-3-(1-(BUT-2-YNOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-A]PYRAZIN-1-YL)-N-(PYRIDIN-2-YL)BENZAMIDE
Timeline
Today
1.7.2016EP application
1.9.2021EP Publication
19.10.2021Translation submitted
15.11.2021Registration published
30.6.2026Expires
Owner
Name:
Acerta Pharma B.V.Address:
Kloosterstraat 9, 5349 AB Oss, NL
Inventor
Name:
BLATTER, FritzAddress:
CH-4153 Reinach, CH
Name:
INGALLINERA, TimAddress:
San Francisco, CA 94117, US
Name:
BARF, TjeerdAddress:
5371 AS Ravenstein, NL
Name:
ARET, EdwinAddress:
1333 CJ Almere, NL
Name:
KREJSA, CecileAddress:
Seattle, WA 98117, US
Name:
EVARTS, JerryAddress:
Bellevue, WA 98007, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562188468 PDate:
2.7.2015Country:
US
Number:
201562271708 PDate:
28.12.2015Country:
US
Classification
Categories:
C07D 487/04, A61K 31/4985, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 20.6.2022
Expires: 30.6.2023
Payer: Patice ehf.
Number: 8
Paid: 21.6.2023
Expires: 30.6.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 3.7.2024
Expires: 30.6.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.7.2025
Expires: 30.6.2026
Payer: Árnason Faktor ehf.